Want to join the conversation?
$NWSA 4Q15 Call: We clearly made strong progress in our second full year. We further digitized our asset portfolio, streamlined costs, and begun to return capital to shareholders. FY15 adjusted revenues were 1% lower than prior year and adjusted total segment EBITDA increased 15% compared to the prior year. FY15 reported EPS were a loss of $0.26.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)